Voyageur Pharmaceuticals Ltd. News
-
Voyageur Pharmaceuticals Signs LOI for Latin America Distribution Partnership Supporting Global Market Expansion
June 24, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“Voyageur”, or the “Company”), a Canadian public company…
-
Voyageur and Altillion Forge Landmark Alliance to Establish North America’s First Vertically Integrated Iodine Drug Supply Chain
June 23, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSXV:VM) (“Voyageur” or the “Company”), a Canadian public company developing cost-effective…
-
Voyageur Enters Revenue Stage with First Commercial Sale of Barium Contrast Agents
June 4, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“Voyageur” or the “Company”), a radiology contrast…
-
Voyageur Pharmaceuticals Announces Appointment of Ethan Mohan as Executive Vice President
May 12, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“Voyageur” or the “Company”) a radiology contrast…
-
Voyageur Pharmaceuticals Announces Changes to Board of Directors and DSU Grant
Ralph Hesje Retires as Chairman Eric Pommer Assumes Role of Chairperson Beth Shaw Appointed to Board May 1,…
-
Voyageur Launches Market Introduction of Barium Contrast Product Line Following Successful Clinical Study Results
Positive feedback received after completion of CDC tests on 24 subjects All key product performance milestones met or…
-
Voyageur Pharmaceuticals Grants Deferred Share Units
April 7, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC: VYYRF) (“Voyageur” or the “Corporation”), a provider…
-
Voyageur Completes Human Testing of Barium Contrast Products and Prepares for Canadian Market Launch
April 1, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“Voyageur” or the “Company”) is pleased to announce…
-
Voyageur Pharmaceuticals Advances Frances Creek Project, Paving the Way for a Secure, Vertically Integrated Barium Contrast Product Line
March 4, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“Voyageur” or the “Company”) is pleased to…
-
Voyageur Clarifies Terms of Previously Announced Agreement
March 3, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) (“Voyageur” or the “Company”) wishes…
